Why are ethnic minorities missing out on genetic medicine? new study aims to find out
NCT ID NCT07309835
First seen Jan 07, 2026 · Last updated Jun 19, 2026 · Updated 25 times
Summary
This study will interview 100 adults from ethnic minority groups, along with community workers and healthcare professionals, to understand why genetic testing services are underused by these communities. The goal is to identify changes that could make genomic medicine more equitable in England. No treatments or interventions are being tested.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GENETIC TESTING are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Guys and St Thomas' NHS foundation Trust
London, United Kingdom
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could point toward structural changes that make genomic medicine more accessible and fair for ethnic minority communities.
What could go wrong
This is an early-stage, small interview study (100 participants) that gathers opinions, not clinical data. It may not lead to direct changes or apply to all regions.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.